Variable attributes. حسب Zhendong Sun (4723221)

الموضوعات:

Vehicle arrival timing on short holidays. حسب Zhendong Sun (4723221)

الموضوعات:

Activity of xylanase in mixed feed and liver (mg saccharide/g sample/h), n = 12/treatment. حسب Miloš Skřivan (5122037)

الموضوعات:

Concentrations of fatty acids in the diet (mg/100 g). حسب Miloš Skřivan (5122037)

الموضوعات:

S2 Appendix - حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

Outcomes and interventions by group comparison. حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

S1 Fig.pdf - حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

Baseline characteristics of participants. حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

Change in Mean Anxiety Scores Over time by group. حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

Participant enrollment. حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

S1 Appendix - حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

Change in STAI scores after counseling. حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

S1 Protocol - حسب Shaaista Budhani (21030221)

"…Forty-three participants in group 1 and 45 participants in group 2 had their pre and post anxiety scores analyzed. There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …"

Johnsen testicular biopsy score. حسب Halime Tozak Yıldız (21238185)

الموضوعات:

Nanoparticle tracking analysis. حسب Halime Tozak Yıldız (21238185)

الموضوعات:

Sperm count and motility. حسب Halime Tozak Yıldız (21238185)

الموضوعات:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer حسب Kaizhao Hu (15670612)

"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"